Genetic variability in the RAGE gene: Possible implications for nutrigenetics, nutrigenomics, and understanding the susceptibility to diabetic complications
- 1 July 2005
- journal article
- review article
- Published by Wiley in Molecular Nutrition & Food Research
- Vol. 49 (7) , 700-709
Abstract
Complex chemical processes called nonenzymatic glycation and glycoxidation are one of the interesting examples of potentially harmful interaction between nutrition and disease. This review summarizes factors influencing the extent of glycoxidation in health and disease and especially focuses on the role of genetic variability in “glycoxidation‐related genes” in a disease and diet‐related pathogenesis. Possible interaction between genetic variability in relevant loci and dietary advanced glycation end products (AGEs) is considered. As AGEs possess a wide range of chemical and biological effects, the interindividual functional variability in systems dealing with glycoxidation could have a significant nutrigenomic and nutrigenetic consequences.Keywords
This publication has 80 references indexed in Scilit:
- Processing of protein glycation, oxidation and nitrosation adducts in the liver and the effect of cirrhosisJournal of Hepatology, 2004
- The AGE of the matrix: chemistry, consequence and cureCurrent Opinion in Pharmacology, 2004
- How to identify gene–environment interactions in a multifactorial disease: CHD as an exampleProceedings of the Nutrition Society, 2004
- Scavenger receptors for oxidized and glycated proteinsAmino Acids, 2003
- RAGE-mediated MAPK activation by food-derived AGE and non-AGE productsBiochemical and Biophysical Research Communications, 2003
- Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis – amelioration by liver transplantationJournal of Hepatology, 2002
- Increase in Three α,β-Dicarbonyl Compound Levels in Human Uremic Plasma: Specificin VivoDetermination of Intermediates in Advanced Maillard ReactionBiochemical and Biophysical Research Communications, 1999
- Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brainNeuroscience Letters, 1996
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- First Evidence for Accumulation of Protein-Bound and Protein-Free Pyrraline in Human Uremic Plasma by Mass SpectrometryBiochemical and Biophysical Research Communications, 1996